# Neuromuscular-Blocking Agents and Hypoxemia During Intubation in Infants (ROC-HYPOX)

> **NCT02589691** · PHASE4 · UNKNOWN · sponsor: **Fondation Ophtalmologique Adolphe de Rothschild** · enrollment: 412 (estimated)

## Conditions studied

- Hypoxemia

## Interventions

- **DRUG:** Rocuronium
- **OTHER:** Sodium chloride 0.9%

## Key facts

- **NCT ID:** NCT02589691
- **Lead sponsor:** Fondation Ophtalmologique Adolphe de Rothschild
- **Sponsor class:** NETWORK
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-12-23
- **Primary completion:** 2024-12-23
- **Final completion:** 2025-12-23
- **Target enrollment:** 412 (ESTIMATED)
- **Last updated:** 2023-07-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02589691

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02589691, "Neuromuscular-Blocking Agents and Hypoxemia During Intubation in Infants (ROC-HYPOX)". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02589691. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*